HYDERABAD : Aurobindo Pharma Limiteds consolidated net profit after JV share and minority interest was up by 45.2 per cent to ₹849.8 crore for the quarter ended March 31, 2020 against ₹585.4 crore during the same quarter in FY '19.
According to a filing with stock exchanges, the drug- maker said the consolidated revenue from operations grew by 16.4 per cent to ₹6,158.4 crore during the quarter under discussion against ₹5292.2 crore in the last quarter of FY '19.
For the full year 2019-20, revenue from operations was at ₹23,098.5 crore witnessing a growth of 18.1 per cent over 2018-19.
The net profit, after JV share and minority interest, jumped by 19.7 per cent to ₹2,831 crore as against ₹2,364. 7 crore in FY '19.